Strengths and Limitations of Using the Polypill in Cardiovascular Prevention
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Link
http://link.springer.com/content/pdf/10.1007/s11886-017-0853-y.pdf
Reference33 articles.
1. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ. 2003 Jun 28;326(7404):1419.
2. • Bramlage P, Sims H, Minguet J, Ferrero C. The polypill: an effective approach to increasing adherence and reducing cardiovascular event risk. Eur J Prev Cardiol. 2017;24(3):297–310. This paper provides a comprehensive review of studies on polypill and their impact on adherence. It also summarises ongoing trials of polypill
3. GBD 2015. Mortality and causes of death collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1459–544.
4. Reddy KS. Cardiovascular disease in non-western countries. N Engl J Med. 2004 Jun 10;350(24):2438–40.
5. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European Society of Cardiology and Other Societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315–81.
Cited by 52 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Fabrication of micro spherulitic particles of carbamazepine-hesperetin cocrystal via QESD with enhanced manufacturability and dissolution;Particuology;2024-10
2. Extrusion-based 3D printing for development of complex capsular systems for advanced drug delivery;International Journal of Pharmaceutics;2024-09
3. Advancing personalized medicine with 3D printed combination drug therapies: A comprehensive review of application in various conditions;European Polymer Journal;2024-07
4. 3D printing processes in precise drug delivery for personalized medicine;Biofabrication;2024-04-17
5. Definition of Polypharmacy in Heart Failure: A Scoping Review of the Literature;Cardiology Research;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3